Compounds > arsenic trioxide
Page last updated: 2024-08-21

arsenic trioxide and Glioma

arsenic trioxide has been researched along with Glioma in 38 studies

Research

Studies (38)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's12 (31.58)29.6817
2010's22 (57.89)24.3611
2020's4 (10.53)2.80

Authors

AuthorsStudies
Cheratta, AR; Galadari, S; Pallichankandy, S; Rangnekar, VM; Subburayan, K; Tariq, S; Thayyullathil, F1
Cheng, Y; Fan, X; Li, F; Lu, Y; Ma, R; Piao, JG; Shi, X; Zheng, H; Zou, J1
Fang, Y; Zhang, Z1
Li, C; Li, F; Piao, JG; Wang, B; Wei, Y; Xu, H; Zheng, H1
Chandler, J; Fountas, L; Grimm, S; Helenowski, I; Kumthekar, P; Levy, R; Marymont, M; McCarthy, K; Mehta, M; Muro, K; Raizer, J1
Alley, K; Beauchamp, EM; Bell, JB; Berens, ME; Cheng, SY; Clymer, J; Dhruv, HD; Eckerdt, F; Finlay, D; Goldman, S; Horbinski, C; James, CD; Kim, S; Kroczynska, B; Kumthekar, P; Mazar, AP; Nakano, I; Peng, S; Platanias, LC; Raizer, J; Vuori, K1
Hu, J; Liu, JH; Wang, GB; Xue, K1
Han, SP; Huang, AH; Li, FZ; Lu, YP; Ma, R; Zheng, HS1
Han, S; Li, F; Lu, Y; Ma, R; Ping, Y; Tang, H; Xu, X; Zhang, Y; Zheng, H; Zou, J1
Fei, W; Li, C; Li, F; Mu, C; Tang, H; Tao, J; Zheng, H; Zhu, Z1
Aniceto, N; Astier, A; Becherirat, S; Gibaud, S; Lanhers, MC; Loboda, C; Socha, M; Yemloul, M1
Chan, TC; Chang, WR; Chiou, SH; Fang, KM; Lin, TC; Liu, JJ; Ma, SZ; Tzeng, SF; Tzou, BC; Yang, CS1
Chen, X; Fu, C; Gao, C; Han, D; Ji, Z; Li, H; Li, X; Liu, H; Liu, Y; Liu, Z; Shi, H; Wang, C; Wang, L; Wu, J; Yang, G; Yin, F; Zhang, D; Zhao, S1
Albrecht, J; Alonso, FJ; Campos-Sandoval, JA; Cardona, C; Cheng, T; Colquhoun, A; Crisma, AR; Curi, R; Deberardinis, RJ; Gómez-García, MC; Higuero, A; Lobo, C; Márquez, J; Martín-Rufián, M; Matés, JM; Nascimento-Gomes, R; Segura, JA; Szeliga, M1
Cai, Y; Chen, C; Chen, S; Huang, J; Lu, X; Wang, Z; Wu, Q; Yang, Q; Zhu, L1
Gülden, M; Klauser, E; Maser, E; Seibert, H; Seibert, S1
Chen, X; Liu, Y; Wang, C; Zhao, S; Zou, H1
Chen, XF; Han, DY; Sun, QX; Zhao, HB; Zhao, SG1
Jiang, C; Li, Y; Wang, J1
Mason, RP; Sarkaria, JN; Zhang, L; Zhang, Z; Zhao, D1
Chen, Y; Cheng, Y; Li, H; Li, Y; Ma, C; Mu, Q; Song, Y; Xu, H; Xu, S; Yu, H; Zhao, G1
Huang, ZS; Qi, TW; Wu, XJ; Xia, ZB1
Lee, TC; Lee, YJ; Liu, SY; Wen, CY1
Chen, Z; Song, X; Wu, C; Zhao, S1
Liang, Y; Liu, Y; Shi, C; Sun, Z; Yang, G; Zhang, X; Zhao, S; Zheng, T1
Chiu, HW; Ho, YS; Wang, YJ1
Chandler, JP; Grimm, SA; Jovanovic, B; Levy, RM; Marymont, M; McCarthy, K; Muro, K; Newman, SB; Raizer, JJ1
Germano, I; Ito, H; Kanzawa, T; Kondo, S; Kondo, Y1
Brannon, J; Dent, P; Fisher, PB; Gopalkrishnan, RV; Grant, S; Lebedeva, IV; Linehan, WM; McKinstry, R; Mitchell, C; Qiao, L; Rosenberg, E; Sarkar, D; Su, ZS; Valerie, K; Yacoub, A1
Brown, SL; Kim, JH; Kolozsvary, A; Lew, YS; Ryu, S1
Germano, IM; Kanzawa, T; Kondo, S; Kondo, Y; Xiao, L; Zhang, L1
Knox, SJ; Ning, S1
Chen, RJ; Cheng, TJ; Ho, YS; Kao, WW; Wang, YJ1
Dong, X; Sun, X; Zhang, J; Zhang, X; Zhao, S1
Choi, KS; Kim, EH; Kim, SU; Kwon, TK; Sohn, S; Yoon, MJ1
Chou, FP; Kuo, HC; Lin, TH; Lu, FJ1
Chen, H; Ge, Y; Gu, J; Jiang, J; Liu, D; Wei, Y; Xu, J; Yun, X; Zhou, F1
Dong, X; Liu, Y; Sun, X; Zhang, J; Zhang, X; Zhao, S; Zou, H1

Reviews

1 review(s) available for arsenic trioxide and Glioma

ArticleYear
Arsenic trioxide as a novel anti-glioma drug: a review.
    Cellular & molecular biology letters, 2020, Volume: 25

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Autophagy; Glioma; Humans; Leukemia, Promyelocytic, Acute

2020

Trials

2 trial(s) available for arsenic trioxide and Glioma

ArticleYear
A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas.
    Journal of neuro-oncology, 2017, Volume: 133, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Arsenic Trioxide; Arsenicals; Brain Neoplasms; Chemoradiotherapy; Dacarbazine; Drug Therapy, Combination; Female; Glioma; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Oxides; Temozolomide; Treatment Outcome; Young Adult

2017
Phase I study of arsenic trioxide and temozolomide in combination with radiation therapy in patients with malignant gliomas.
    Journal of neuro-oncology, 2012, Volume: 110, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Brain Neoplasms; Chemoradiotherapy; Dacarbazine; Dose Fractionation, Radiation; Female; Glioma; Humans; Male; Maximum Tolerated Dose; Middle Aged; Oxides; Prognosis; Radiotherapy Dosage; Survival Rate; Temozolomide

2012

Other Studies

35 other study(ies) available for arsenic trioxide and Glioma

ArticleYear
Par-4 regulates autophagic cell death in human cancer cells via upregulating p53 and BNIP3.
    Biochimica et biophysica acta. Molecular cell research, 2020, Volume: 1867, Issue:7

    Topics: Apoptosis; Apoptosis Regulatory Proteins; Arsenic Trioxide; Autophagic Cell Death; Cell Line, Tumor; Curcumin; Gene Expression Regulation, Neoplastic; Glioma; Humans; Membrane Proteins; Proto-Oncogene Proteins; Transcriptional Activation; Tumor Suppressor Protein p53

2020
iRGD and TGN co-modified PAMAM for multi-targeted delivery of ATO to gliomas.
    Biochemical and biophysical research communications, 2020, 06-18, Volume: 527, Issue:1

    Topics: Antineoplastic Agents; Arsenic Trioxide; Blood-Brain Barrier; Brain; Brain Neoplasms; Cell Line; Dendrimers; Drug Carriers; Drug Delivery Systems; Glioma; Humans; Oligopeptides; Tissue Distribution

2020
Angiopep-2-modified calcium arsenite-loaded liposomes for targeted and pH-responsive delivery for anti-glioma therapy.
    Biochemical and biophysical research communications, 2021, 04-30, Volume: 551

    Topics: Animals; Arsenic Trioxide; Arsenites; Blood-Brain Barrier; Calcium; Cell Cycle; Cell Line, Tumor; Drug Delivery Systems; Glioma; Humans; Hydrogen-Ion Concentration; Liposomes; Mice; Mice, Nude; Peptides; Tissue Distribution; Xenograft Model Antitumor Assays

2021
Differential Response of Glioma Stem Cells to Arsenic Trioxide Therapy Is Regulated by MNK1 and mRNA Translation.
    Molecular cancer research : MCR, 2018, Volume: 16, Issue:1

    Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Cell Line, Tumor; Cell Proliferation; Glioma; Humans; Intracellular Signaling Peptides and Proteins; Mice; Neoplastic Stem Cells; Protein Serine-Threonine Kinases; RNA, Messenger; Signal Transduction; Xenograft Model Antitumor Assays

2018
Mechanism of As2O3 induces apoptosis of glioma U87 cells.
    European review for medical and pharmacological sciences, 2017, Volume: 21, Issue:21

    Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Arsenic Trioxide; Arsenicals; Caspase 3; Caspase 9; Cell Count; Cell Line, Tumor; Dose-Response Relationship, Drug; Down-Regulation; Glioma; Humans; Oxides; Tumor Suppressor Protein p53

2017
[Preparation and
    Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2018, Volume: 43, Issue:8

    Topics: Arsenic Trioxide; Cell Line, Tumor; Dendrimers; Drug Carriers; Drug Delivery Systems; Glioma; Humans; Polyethylene Glycols

2018
A novel RGDyC/PEG co-modified PAMAM dendrimer-loaded arsenic trioxide of glioma targeting delivery system.
    International journal of nanomedicine, 2018, Volume: 13

    Topics: Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Blood-Brain Barrier; Cell Cycle; Cell Line, Tumor; Dendrimers; Drug Carriers; Drug Delivery Systems; Drug Liberation; Endocytosis; Glioma; Humans; Male; Mice; Oligopeptides; Oxides; Polyethylene Glycols; Rabbits; Rats; Static Electricity; Treatment Outcome

2018
Angiopep-2-Conjugated "Core-Shell" Hybrid Nanovehicles for Targeted and pH-Triggered Delivery of Arsenic Trioxide into Glioma.
    Molecular pharmaceutics, 2019, 02-04, Volume: 16, Issue:2

    Topics: Animals; Arsenic Trioxide; Blood-Brain Barrier; Cell Cycle; Cell Line, Tumor; Drug Carriers; Endothelial Cells; Glioma; Humans; Hydrogen-Ion Concentration; Microscopy, Confocal; Microscopy, Electron, Transmission; Nanoparticles; Peptides; Rats; Rats, Sprague-Dawley

2019
The antitumor effects of an arsthinol-cyclodextrin complex in a heterotopic mouse model of glioma.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2013, Volume: 85, Issue:3 Pt A

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; beta-Cyclodextrins; Brain Neoplasms; Cell Line, Tumor; Excipients; Female; Glioma; Humans; Injections, Intraperitoneal; Magnetic Resonance Spectroscopy; Melarsoprol; Mice; Mice, Nude; Oxides; Xenograft Model Antitumor Assays

2013
Enhanced cell growth and tumorigenicity of rat glioma cells by stable expression of human CD133 through multiple molecular actions.
    Glia, 2013, Volume: 61, Issue:9

    Topics: AC133 Antigen; Animals; Antigens, CD; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Basic Helix-Loop-Helix Transcription Factors; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic; Cerebral Cortex; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Formazans; Gene Expression Regulation, Neoplastic; Glioma; Glycoproteins; GTPase-Activating Proteins; Homeodomain Proteins; Humans; Intercellular Signaling Peptides and Proteins; Lentivirus; Oncogene Protein v-akt; Oxides; Peptides; Rats; Rats, Sprague-Dawley; Receptor, Notch1; RNA, Messenger; RNA, Small Interfering; Tetrazolium Salts; Time Factors; Transcription Factor HES-1; Transfection; Tumor Stem Cell Assay

2013
Low-dose arsenic trioxide enhances 5-aminolevulinic acid-induced PpIX accumulation and efficacy of photodynamic therapy in human glioma.
    Journal of photochemistry and photobiology. B, Biology, 2013, Oct-05, Volume: 127

    Topics: Aminolevulinic Acid; Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Glioma; Heme; Humans; Intracellular Space; Oxides; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Rats; Rats, Wistar

2013
Both GLS silencing and GLS2 overexpression synergize with oxidative stress against proliferation of glioma cells.
    Journal of molecular medicine (Berlin, Germany), 2014, Volume: 92, Issue:3

    Topics: Antioxidants; Apoptosis; Arsenic Trioxide; Arsenicals; BH3 Interacting Domain Death Agonist Protein; Brain Neoplasms; Cell Movement; Cell Proliferation; Cell Survival; Flow Cytometry; Gene Silencing; Glioma; Glutaminase; Glutathione; Humans; Mitochondria; Oxidative Stress; Oxides; Proto-Oncogene Proteins c-myc; Reactive Oxygen Species; Staining and Labeling

2014
Arsenic trioxide targets miR-125b in glioma cells.
    Current pharmaceutical design, 2014, Volume: 20, Issue:33

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Cycle; Cell Proliferation; Drug Screening Assays, Antitumor; Glioma; Humans; MicroRNAs; Oxides; Structure-Activity Relationship; Tumor Cells, Cultured

2014
Additivity, antagonism, and synergy in arsenic trioxide-induced growth inhibition of C6 glioma cells: effects of genistein, quercetin and buthionine-sulfoximine.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2014, Volume: 67

    Topics: Animals; Arsenic Trioxide; Arsenicals; Brain Neoplasms; Buthionine Sulfoximine; Cell Division; Cell Line, Tumor; Genistein; Glioma; Oxides; Quercetin; Rats

2014
The roles of mitoferrin-2 in the process of arsenic trioxide-induced cell damage in human gliomas.
    European journal of medical research, 2014, Sep-26, Volume: 19

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cation Transport Proteins; Cell Line, Tumor; Glioma; Humans; Oxides; Reactive Oxygen Species

2014
Efficacy of intratumoral chemotherapy using arsenic trioxide (As2O3) sustained release tablets for the treatment of neurogliocytoma in nude mice.
    European review for medical and pharmacological sciences, 2014, Volume: 18, Issue:17

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Brain Neoplasms; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Glioma; Injection, Intratympanic; Lactic Acid; Mice; Mice, Inbred BALB C; Mice, Nude; Oxides; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Random Allocation; Tablets

2014
MiR-133b contributes to arsenic-induced apoptosis in U251 glioma cells by targeting the hERG channel.
    Journal of molecular neuroscience : MN, 2015, Volume: 55, Issue:4

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cells, Cultured; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Glioma; Humans; MicroRNAs; Neurons; Oxides

2015
Convertible MRI contrast: Sensing the delivery and release of anti-glioma nano-drugs.
    Scientific reports, 2015, May-12, Volume: 5

    Topics: Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Contrast Media; Drug Delivery Systems; Drug Resistance, Neoplasm; Glioma; Humans; Magnetic Resonance Imaging; Manganese; Nanoparticles; Oxides; Radiography

2015
Arsenic trioxide inhibits glioma cell growth through induction of telomerase displacement and telomere dysfunction.
    Oncotarget, 2016, Mar-15, Volume: 7, Issue:11

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Proliferation; DNA Damage; Glioma; Humans; Oxides; Protein Transport; Telomerase; Telomere

2016
[Study on inhibitory effect of arsenic trioxide on growth of rat C6 glioma cells].
    Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2008, Volume: 33, Issue:17

    Topics: Animals; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Glioma; Male; Oxides; Rats; Rats, Sprague-Dawley

2008
XPC silencing sensitizes glioma cells to arsenic trioxide via increased oxidative damage.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 116, Issue:1

    Topics: Arsenic Trioxide; Arsenicals; Autophagy; Base Sequence; Brain Neoplasms; Cell Line, Tumor; Cellular Senescence; DNA-Binding Proteins; Fluorescent Antibody Technique; Gene Silencing; Glioma; Humans; Oxidative Stress; Oxides; RNA, Small Interfering

2010
Abrogating HSP response augments cell death induced by As2O3 in glioma cell lines.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2010, Volume: 37, Issue:4

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Benzhydryl Compounds; Caspase 3; Cell Death; Cell Line, Tumor; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Flow Cytometry; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Glioma; Heat Shock Transcription Factors; Heat-Shock Proteins; Heat-Shock Response; Humans; MAP Kinase Kinase 4; Membrane Potential, Mitochondrial; Oxides; Pyrrolidinones; RNA, Small Interfering; Time Factors; Transcription Factors; Trypan Blue

2010
Inhibition of heme oxygenase-1 enhances anti-cancer effects of arsenic trioxide on glioma cells.
    Journal of neuro-oncology, 2011, Volume: 104, Issue:2

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blotting, Western; Cell Line, Tumor; Enzyme Inhibitors; Gene Knockdown Techniques; Glioma; Heme Oxygenase-1; Humans; NF-E2-Related Factor 2; Oxides; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction

2011
Arsenic trioxide induces autophagy and apoptosis in human glioma cells in vitro and in vivo through downregulation of survivin.
    Journal of molecular medicine (Berlin, Germany), 2011, Volume: 89, Issue:9

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Autophagy; Cell Cycle; Cell Survival; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Glioma; Humans; Inhibitor of Apoptosis Proteins; Male; Mice; Mice, SCID; Mitogen-Activated Protein Kinases; Oxides; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; Signal Transduction; Survivin; Tumor Burden

2011
Induction of autophagic cell death in malignant glioma cells by arsenic trioxide.
    Cancer research, 2003, May-01, Volume: 63, Issue:9

    Topics: Amino Acid Chloromethyl Ketones; Anti-Bacterial Agents; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Autophagy; Caspase Inhibitors; Cell Division; Cytoplasm; Drug Interactions; Enzyme Inhibitors; G2 Phase; Glioma; Humans; Macrolides; Mitosis; Oxides; Tumor Cells, Cultured

2003
MDA-7 (interleukin-24) inhibits the proliferation of renal carcinoma cells and interacts with free radicals to promote cell death and loss of reproductive capacity.
    Molecular cancer therapeutics, 2003, Volume: 2, Issue:7

    Topics: Acetylcysteine; Adenoviridae; Adjuvants, Immunologic; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-X Protein; Brain Neoplasms; Carcinoma, Renal Cell; Caspases; Cell Division; Free Radical Scavengers; Free Radicals; Genes, Tumor Suppressor; Glioma; Glutathione Transferase; Humans; Interleukins; Kidney; Kidney Neoplasms; Oxides; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Receptors, Virus; Recombinant Fusion Proteins; Tumor Cells, Cultured

2003
Arsenic trioxide enhances radiation response of 9L glioma in the rat brain.
    Radiation research, 2003, Volume: 160, Issue:6

    Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Brain Neoplasms; Combined Modality Therapy; Glioma; Magnetic Resonance Imaging; Male; Oxides; Rats; Rats, Inbred F344

2003
Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3.
    Oncogene, 2005, Feb-03, Volume: 24, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Autophagy; Blotting, Western; Brain Neoplasms; Gene Expression Profiling; Glioma; Humans; Membrane Proteins; Oligonucleotide Array Sequence Analysis; Oxides; Proto-Oncogene Proteins; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured; Up-Regulation

2005
Optimization of combination therapy of arsenic trioxide and fractionated radiotherapy for malignant glioma.
    International journal of radiation oncology, biology, physics, 2006, Jun-01, Volume: 65, Issue:2

    Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Brain Neoplasms; Combined Modality Therapy; Dose Fractionation, Radiation; Glioma; Humans; Male; Mice; Mice, Nude; Oxides; Transplantation, Heterologous; Tumor Cells, Cultured

2006
Protection against arsenic trioxide-induced autophagic cell death in U118 human glioma cells by use of lipoic acid.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2007, Volume: 45, Issue:6

    Topics: Acridine Orange; Antioxidants; Apoptosis Regulatory Proteins; Arsenic Poisoning; Arsenic Trioxide; Arsenicals; Autophagy; Blotting, Western; Cell Line, Tumor; Drug Interactions; Electrophoresis, Agar Gel; Flow Cytometry; Fluorescent Dyes; Glioma; Humans; Neuroglia; Oxides; Thioctic Acid

2007
Arsenic trioxide induces different gene expression profiles of genes related to growth and apoptosis in glioma cells dependent on the p53 status.
    Molecular biology reports, 2008, Volume: 35, Issue:3

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glioma; Humans; Oxides; RNA, Messenger; Tumor Suppressor Protein p53

2008
Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation.
    Cancer research, 2008, Jan-01, Volume: 68, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Astrocytes; Brain Neoplasms; Caspase 3; Glioma; Humans; Membrane Proteins; Oxides; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins; Receptors, TNF-Related Apoptosis-Inducing Ligand; RNA, Small Interfering; TNF-Related Apoptosis-Inducing Ligand; Transcription Factor CHOP; Tumor Cells, Cultured; Up-Regulation

2008
Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide.
    BMC cancer, 2008, Feb-25, Volume: 8

    Topics: Actins; Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Berberine; Cell Line, Tumor; Cell Movement; Cell Proliferation; Enzyme Activation; Glioma; Humans; Isoenzymes; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Oxides; Protein Kinase C-alpha; Protein Kinase C-epsilon; Rats; Transcription Factors; Translocation, Genetic

2008
Down-regulation of beta1,4GalT V at protein level contributes to arsenic trioxide-induced glioma cell apoptosis.
    Cancer letters, 2008, Aug-18, Volume: 267, Issue:1

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; DNA, Antisense; Down-Regulation; Galactosyltransferases; Glioma; Humans; Optic Nerve Injuries; Oxides; Polysaccharides

2008
Intravenous administration of arsenic trioxide encapsulated in liposomes inhibits the growth of C6 gliomas in rat brains.
    Journal of chemotherapy (Florence, Italy), 2008, Volume: 20, Issue:2

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Brain Neoplasms; Drug Stability; Glioma; Injections, Intravenous; Liposomes; Male; Microscopy, Electron; Neovascularization, Pathologic; Oxides; Rats; Rats, Wistar; Tissue Distribution

2008